智通财经APP讯，亚虹医药(688176.SH)发布2026年员工持股计划(草案)，持股计划经公司股东会审议批准后，将通过非交易过户等法律法规允许的方式取得并持有公司回购专用证券账户所持有的公司股份，合计不超过587.1735万股，约占公司当前股本总额的1.03%。其中拟首次授予476万股，预留111.1735万股。
持股计划的存续期为60个月，自公司公告首次授予部分最后一笔标的股票过户至本员工持股计划名下之日起算。本员工持股计划首次授予部分所获标的股票分两期解锁，解锁时点分别为自公司公告首次授予部分最后一笔标的股票过户至本员工持股计划名下之日起满12个月、24个月，每期解锁的标的股票比例分别为50%、50%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.